Inflammation mediated vascular lesions

摘要

Preventing, managing or reversing disease which is caused by inflammation mediated vascular lesions using an agent which substantially inhibits the at least one of infiltration and/or accumulation of inflammatory cells proximate a site of altered vascular tissue. The agent can comprise a FKBP binding and mTOR inhibiting capacity agent.